GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update
Nov 11, 2016 12:30 pm UTC| Business
TORONTO, Nov. 11, 2016 -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today reported operational and financial results for the three-month period ended September 30, 2016. Corporate Update The third...
Nov 11, 2016 12:30 pm UTC| Business
Phase 1 AXAL and durvalumab combination trial shows safety and tolerability in cervical and HPV+ head and neck cancerPreclinical data demonstrate synergistic antitumor effects of AXAL combined with a CD137 agonistic...
Nov 11, 2016 12:18 pm UTC| Business
NEW YORK, Nov. 11, 2016 -- AmTrust Financial Services, Inc. (Nasdaq:AFSI) (the “Company” or “AmTrust”) today announced that it has finalized its quarterly report on Form 10-Q for the third quarter 2016 and will submit...
BioSig Technologies To Present Today At The Emerging Medical Technologies Summit
Nov 11, 2016 12:15 pm UTC| Business
Minneapolis, MN, Nov. 11, 2016 -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) signal acquisition and analysis system, today...
AC Immune Reports Third Quarter 2016 Results
Nov 11, 2016 12:12 pm UTC| Business
LAUSANNE, Switzerland, Nov. 11, 2016 -- AC Immune SA (NASDAQ:ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced financial results for the third quarter...
Nov 11, 2016 12:00 pm UTC| Business
Expands Supply Chain Messaging Capabilities in Australia WATERLOO, Ontario, Nov. 11, 2016 -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting logistics-intensive businesses in commerce,...
Nov 11, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed against tumor...